Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Non Operating Income (2019 - 2026)

Updated

Revolution Medicines (RVMD) recorded Non Operating Income of -$139.24 million in Q2 2026, compared with $16.93 million a year earlier.

Analysis

Revolution Medicines (RVMD) Non Operating Income (2019 - 2026) Analysis & Trends

On a TTM basis, Revolution Medicines' Non Operating Income came in at -$141.04 million as of Jun 30, 2026; for FY2025, it was $51.07 million, down 42.4% from FY2024.

  • Annual Non Operating Income has a five-year compound annual growth rate of 88.1% (FY2020 to FY2025).
  • Across earlier years, Non Operating Income came in at $88.68 million in FY2024 (+87.5%), $47.29 million in FY2023 (+416.6%), $9.15 million in FY2022 (+898.3%) and $917,000 in FY2021 (-57.7%).
  • The Q2 2026 figure is the lowest quarterly Non Operating Income in data going back to Q1 2019.
  • On a year-over-year basis, Non Operating Income rose in three of the last five quarters, with growth averaging 4.7%.
  • Peak year-over-year performance for Non Operating Income in the last five years was growth of 276.6% in Q3 2023, against a decline of 48.2% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$8.59 million (Q1 2026), -$3.27 million (Q4 2025) and $10.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 387.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Revolution Medicines 37.70 Bn 27.90 Bn - -139.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -139.24 Mn
Mar 31, 2026 -8.59 Mn
Dec 31, 2025 -3.27 Mn
Sep 30, 2025 10.06 Mn
Jun 30, 2025 16.93 Mn
Mar 31, 2025 27.34 Mn
Dec 31, 2024 20.99 Mn
Sep 30, 2024 19.42 Mn
Jun 30, 2024 23.41 Mn
Mar 31, 2024 24.86 Mn
Dec 31, 2023 18.79 Mn
Sep 30, 2023 10.95 Mn
Jun 30, 2023 10.50 Mn
Mar 31, 2023 7.06 Mn
Dec 31, 2022 5.08 Mn
Sep 30, 2022 2.91 Mn
Jun 30, 2022 867,000.00
Mar 31, 2022 302,000.00
Dec 31, 2021 237,000.00
Sep 30, 2021 223,000.00
API Access

Revolution Medicines Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=RVMD&period=max&api_key=YOUR_API_KEY